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SURGICAL IMPLANTATION OF RADIO TRANSMITTERS IN
ARCTIC FOXES (ALOPEX LAGOPUS) ON SVALBARD, NORWAY
Eva Fuglei, Ph.D., James B. Mercer, Ph.D., and Jon M. Arnemo, D.V.M., Ph.D.
Abstract: Twelve captive wild-caught adult arctic foxes (Alopex lagopus) were anesthetized a total of 24 times for
an equal number of surgical procedures involving implantation of heart rate (HR) and core body temperature transmitters
(Tb) between October 1995 and April 1997. Xylazine–ketamine and medetomidine–ketamine anesthesia was used,
resulting in an unacceptably high death rate. One out of four foxes anesthetized with xylazine–ketamine died, whereas
two of nine foxes anesthetized with medetomidine–ketamine died out of a total of 20 surgical procedures. Durations
of the surgeries for implantation of Tb transmitters and HR transmitters were 73 6 7 min and 95 6 13 min, respectively.
Key words: Alopex lagopus, arctic fox, ketamine, medetomidine, xylazine, radio transmitter.
INTRODUCTION
The arctic fox (Alopex lagopus) has a circum-
polar distribution. It lives above the tree line in al-
pine areas in Fennoscandia, on the tundra mainland
of arctic Eurasia and North America, and on islands
in the Arctic, North Atlantic, and North Pacific
oceans and ranges widely over the pack ice. On the
Svalbard archipelago, Norway, these foxes experi-
ence extreme contrasts in light and temperature,
and periodic limitations of food availability. The
sun remains above the horizon from mid April to
late August, resulting in 24 hr of daylight. In con-
trast, the sun is below the horizon from late October
to mid February, which results in 24 hr darkness
from mid November to the end of January.8 Food
is abundant during the summer (May–July) and
sparse during winter (November–March). The arc-
tic fox, in spite of its small body size, manages to
overcome the extreme variations in its environment
and survive year-round in the high Arctic—a re-
markable feat.
Little information has been published on the
physiologic adaptations of the arctic fox to these
conditions. Before studying physiologic adaptations
in free-ranging animals, basic standardized exami-
nations should be carried out in the laboratory. Two
important physiologic parameters, heart rate (HR)
and core body temperature (Tb), can be monitored
in the species using radiotelemetry, although the
small transmitters have short transmission ranges
and brief battery life. Effective surgical protocols
and techniques for the implantation of these trans-
mitters in arctic foxes are needed.
From the Norwegian Polar Institute, NO-9296 Tromsø,
Norway (Fuglei); Department of Medical Physiology,
Faculty of Medicine, University of Tromsø, NO-9037
Tromsø, Norway (Mercer); and Department of Arctic Vet-
erinary Medicine, The Norwegian School of Veterinary
Science, NO-9292 Tromsø, Norway (Arnemo). Corre-
spondence should be directed to Dr. Fuglei.
Xylazine has been the most commonly used 2-a´
adrenoceptor agonist for sedation and immobiliza-
tion of animals.13 The newer 2-adrenoceptor ago-a´
nist, medetomidine, which is more selective and
potent than xylazine, has dose-dependent sedative,
analgesic, and muscle-relaxing properties in ca-
nids.13,16 However, a complete and reliable immo-
bilization requires the addition of a potent anes-
thetic agent such as ketamine.12,16 Medetomidine–
ketamine combinations have been used successfully
in a wide range of domestic and nondomestic mam-
mals12,15 including such canids such as the gray
wolf (Canis lupus),9,16 red wolf (Canis rufus),23 and
farmed blue fox (Alopex lagopus).11 Only one study
has used medetomidine and ketamine in free-rang-
ing arctic foxes.1
Our study evaluated anesthesia induced by xy-
lazine–ketamine and medetomidine–ketamine in
arctic foxes and sought to develop a reliable tech-
nique for the surgical implantation and replacement
of HR and Tb transmitters. The animals implanted
with the transmitters were later used in studies to
investigate the physiologic adaptation of the ani-
mals to high arctic conditions.3–6
MATERIALS AND METHODS
Animals
Twelve 2.8–5.2 kg adult arctic foxes, including
1 female and 11 males, were captured between
1993 and 1996 in baited live traps near Ny-A˚ lesund
(788559N, 118569E), Svalbard, Norway. Two of the
foxes (all males) were captured in 1993, six in 1994
(five males, one female), two in 1995 (all males),
and two in 1996 (all males). The foxes were held
individually throughout the year in outdoor adja-
cent wooden-framed cages (2.5-m long 3 2-m wide
3 2-m high) at the Field Research Station of the
Norwegian Polar Institute in Ny-A˚ lesund, Svalbard,
Norway. Foxes were held in captivity for 28 6 14
mo (range: 4–51). The cage walls, floor, and roof
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Table 1. Ambient temperature (Ta) of the outdoor cages, body weight (BW), number of heart rate (HR) and core
body temperature (Tb) transmitters implanted, and number of surgeries carried out in 12 arctic foxes on Svalbard in
1995, 1996, and 1997.
Measure
Oct 1995
(n 5 9)
Apr 1996
(n 5 8)
Apr 1997
(n 5 7)
Ta (8C) 26 to 213 29 to 213 23 to 211
BW (kg) 4.0 6 0.7 4.0 6 0.7 4.0 6 0.8
(Range) (3.1–5.2) (3.1–5.2) (2.8–5.0)
No. of HR transmitter im-
planted 4 3 5
No. of Tb transmitter im-
planted 4 3 0
No. of transmitters remo-
veda — — 2
No. animals having first
procedure 9 initial implantations (1
died)
2 initial implantations 1 initial implantation
No. of animals having
second procedure — 6 replacements (2 died) 2 replacements
No. of animals having
third procedure — — 4 (two replacements, two
removals)
a Transmitters removed 5 removal only of previously implanted transmitter.
were covered with a plastic-coated wire mesh net-
ting, and inside each cage was a wooden kennel
(0.5-m long 3 0.5-m wide 3 1-m high). Dry food
(FK-Revepellets, Felleskjøpet, Norway) softened in
water, and water were provided ad lib. Freezing of
food and water was prevented during the winter by
use of thermostatically controlled heating elements
in the foodbox. Ambient temperatures in the out-
door cages at the time of the year during which the
surgical procedures were carried out are shown in
Table 1.
Surgical implantation
All surgical procedures were performed at the
field research station in Ny-A˚ lesund, Svalbard,
Norway. A room adjacent to the outdoor holding
facility was used as a field operating theater. Tem-
perature in the surgical suite was maintained at 20–
258C. A total of 24 anesthesia–surgical procedures
was performed from 1995 through 1997, including
transmitter implantations, transmitter replacements,
and transmitter removals (Table 1). Anesthesia and
surgical implantation of transmitters were carried
out in nine foxes in October 1995 (in 1 female that
died under anesthesia and in 8 of the 11 males). In
April 1996, eight male foxes had surgical proce-
dures performed (six of these males had their first
surgical implantations in 1995, and these six male
foxes had their transmitters replaced, whereas the
remaining two had new transmitters implanted). In
April 1997, seven male foxes had surgical proce-
dures performed (five had implantations, and two
had transmitters removed but not replaced). Four of
these males had transmitters initially implanted in
1995, replaced once before in 1996. Of these four,
two had the transmitter replaced a third time, and
two had a transmitter removed but not replaced in
1997. Two of the seven males had transmitters ini-
tially implanted in 1996; both the males had the
transmitter replaced in 1997. One of these seven
males had a HR transmitter implanted for the first
time. All surgery involving the implantation of HR
and Tb radio transmitters was performed under
aseptic conditions and under general anesthesia.
The foxes were fasted overnight with free access to
drinking water before each anesthesia and surgery.
The animals were weighed approximately 24 hr be-
fore surgery.
In 1995, four of the nine surgeries (involving one
female and three males) were performed with an
anesthetic mixture of xylazine (Rompunt 20 mg/
ml, Bayer AG, Leverkusen, Germany; 1.2 mg/kg,
i.m.) and ketamine (Ketalart 50 mg/ml, Parke-Da-
vis, S. A. Barcelona, Spain; 25 mg/kg, i.m.)10 by
hand injection while the animals were under man-
ual restraint in their cages. The remaining five sur-
geries performed in 1995, and all those performed
in 1996 (n 5 8) and 1997 (n 5 7), used an anes-
thetic mixture of medetomidine (Domitort 1 mg/
ml, Orion Corporation Animal Health, Turku, Fin-
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land; 0.05 mg/kg, i.m.) and ketamine (Ketalart 50
mg/ml, Parke-Davis; 3 mg/ml, i.m.)11 injected to-
gether into the thigh while the animals were in their
outdoor holding cages. The immediate preanesthet-
ic condition and the time from injection to first sign
of sedation (FSS), lateral recumbency (LR), and
complete immobilization (CI) were recorded in fox-
es anesthetized with medetomidine–ketamine only.
The first signs of sedation involved lowering of the
head, reduced alertness, and slight swaying while
standing, whereas LR was characterized as perma-
nent lateral recumbency and CI as no reaction to
handling. The foxes were brought indoors to the
operating theatre after CI was reached outside, and
a catheter (0.8/25 mm, BOC Ohmeda AB, Helsing-
borg, Sweden) was inserted in the cephalic vein to
facilitate administration of supplemental anesthetics
as required. This i.v. line was kept open with a
continuous slow infusion (2–3 ml/min) of physio-
logic saline. Immediately after the induction of an-
esthesia, the animals were given a prophylactic in-
jection of procaine penicillin and dihydrostrepto-
mycine (3 ml of Proca-Mycin vet., 200 mg procaine
penicillin 1 250 mg dihydrostreptomycin/ml; Al-
pharma, Oslo, Norway, i.m.).
Rectal temperature (Tr; Fluke 2176A, multi-point
digital thermometer, Fluke Norge AS, Postboks
6054 Etterstad 0601, Oslo, Norway) and HR (ECG,
diascope DS 521, S&W Medico Teknik A/S, Al-
bertslund, Denmark) were monitored continually
during surgery. Respiratory rate (RR) was deter-
mined sporadically by counting thoracic excur-
sions. Assessment of anesthetic depth was based on
loss of palpebral reflexes and on response to pinch-
ing of the skin between the toes. Peripheral circu-
latory status was assessed by subjective monitoring
of mucus membrane color. Equipment for intuba-
tion and pulmonary ventilation was available in
case of an emergency. Time of occurrence of each
event was recorded after the initial dose of the an-
esthetic—for FSS, LR, CI, total time under anes-
thesia, and for changes in anesthetic depth—and
when supplemental dose of anesthesia was admin-
istered. In addition, the times of occurrence of mis-
cellaneous events such as vomiting or tonic con-
vulsions were also recorded. Supplemental doses of
the same anesthetic combination that was given ini-
tially to a particular animal were administered when
that animal reacted to tactile stimuli (presence of
palpebral or interdigital reflex [or both]). Each sup-
plemental dose was equivalent to 20% of the initial
anesthetic dose.
Radio transmitters
The 6.3-cm-long 3 2.3-cm-wide, 44 g radio
transmitters (DataCol 5.0, Mini Mitter, Oregon
97707, USA) constituted approximately 1% of a
fox’s body weight. The temperature transmitter,
model VHF-T-1, and HR transmitter, model VHF-
C-1, were equipped with lithium batteries (2,000
and 1,600 mAh) that could last for up to 5 mo and
had signal ranges of at least 100 m. A T-shaped
dipole antenna (ANT-1; Mini Mitter, Oregon
97707, USA) and a telemetry receiver (TR-2; Te-
lonics, Arizona 85204-6699, USA) received the
transmitter signals. A cable supplied with the re-
ceiver transmitted the signals to a computer
equipped with DataCol 5.0 hardware and software;
the latter was used for collection, storage, and dis-
play of data. Table 1 gives an overview of the trans-
mitters implanted in 1995, 1996, and 1997. The HR
transmitters came equipped with two silicone-coat-
ed electrodes. The electrodes were cut to a prede-
termined length (9 and 6 cm or a length that gave
a total separation of the electrode tips of approxi-
mately 12–15 cm). Approximately 2 cm of the sil-
icone insulation was removed from the distal (free)
end of each electrode. The exposed electrode wire
was then bent back on itself to form a small noose-
shaped loop. To prevent the loop from opening, a
small piece of silicone tubing was placed on top of
the bare wire, about 1 cm behind the loop (Fig. 1a).
Before implantation, the thin piece of silicone tub-
ing was expanded by soaking it for a few minutes
in xylene. When the xylene evaporated, the silicone
tubing shrunk back to its original size. The mersi-
lene-enclosed transmitter (see below) was then dis-
infected by placement in 70% alcohol for 2 hr be-
fore surgery.
All the eight transmitters implanted in 1995 and
five implanted in 1996 were placed in bags of mer-
silene-net (Ethicon GmbH & Co. KG, Norderstedt,
Germany) to ensure firm adhesion to the abdominal
wall through ingrowth of connective tissue. How-
ever, because it was necessary to replace the old
transmitters with new ones, this turned out to be
impractical. The extensive ingrowth of connective
tissue on the mersilene-netting, which, in some cas-
es extended to other organs such as the liver,
spleen, and stomach, caused excessively vascular-
ized tissue to grow around the transmitter and thus
caused excessive hemorrhage. Therefore, radio
transmitters were implanted without the mersilene
net in the last fox in 1996 and in five animals in
1997. Instead, a thick multifilament, nonabsorbable
suture (Mersilencet Ethicon 1 UPS) that was
formed into three parallel belts around each trans-
mitter was used. Each belt had two small loops on
opposite sides of the transmitter to facilitate attach-
ment to the abdominal wall (Fig. 1c).
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Surgery
The animal was placed in dorsal recumbency,
and the legs were secured to the table. An area
measuring 10 cm 3 5 cm caudal to the umbilicus
was prepared for surgery. The fur was clipped, and
the exposed skin was shaved and disinfected with
chlorhexidine–ethanol (Klorhexidin 5 mg/ml, Ny-
comed Pharma AS, Oslo, Norway). The animal was
then covered with a sterile surgical drape. Each an-
imal received only one type of transmitter at a time.
No animal ever had both types of transmitters im-
planted simultaneously.
A ventral midline incision was made to approach
the abdominal cavity. On both sides of the midline
incision, the skin was dissected from the s.c. tissue
laterally for a distance of about 2 cm. Before the
operation, four absorbable sutures strands (0.48
mm, Ethicon Chrom Catgut) were attached to the
four corners of the mersiline-netting surrounding
the transmitter. Atraumatic needles were attached to
the free end of each of the four suture strands.
These suture strands were used to anchor the trans-
mitter in a stable position abutting the inside wall
of the abdominal cavity. The orientation of the
transmitter inside the abdominal cavity was such
that two of the free suture strands lay toward the
right side and two toward the left side of the ani-
mal. With the aid of the atraumatic needles the su-
ture strands were passed completely through the ab-
dominal wall from the inside to the outside. The
exit sites were located at a distance of about 1.5
cm lateral to the midline, i.e., the sutures did not
pass through the skin. The midline incision in the
abdominal cavity was closed as a single layer with
simple interrupted absorbable sutures (0.48 mm,
Ethicon Chrom Catgut). After the closure of the
abdominal cavity, the transmitter was lifted into its
final position abutting the inside wall of the ventral
abdominal cavity by gently pulling the free ends of
the four anchoring sutures that had been previously
passed through the abdominal wall. The transmitter
was then held in place by keeping the strands taut
and then tying together the two respective right-
and left-hand suture pairs. Care was taken that the
suture knots lay to the side of the midline incision.
The HR transmitters with their two silicone-cov-
ered electrodes were implanted into the abdominal
cavity in a similar fashion. The two HR electrodes
exited the abdominal cavity through the abdominal
incision. These two electrodes were then guided
through s.c. tunnels to their final position. Two
electrode placements under the skin were used (Fig.
1b). In one animal, the first electrode was placed
under the skin above the sternum, whereas the sec-
ond was positioned on the inside of the left axilla.
In the 11 other surgical procedures both electrodes
were fixed in a midline position, one in an anterior
position and the other in a posterior position, 1 cm
off midline, with approximately 15 cm electrode
separation.
In 3 of the 12 HR transmitter implantations, the
tips of the electrodes were located by palpation of
the skin. The skin overlying the electrode was
shaved, and a small skin incision was made. The
exposed electrode tip was sutured to the underlying
tissue with an absorbable suture. In four of the HR
implantations, the electrodes were not anchored,
and in five implantations the leads were sutured
with three stitches to the underlying tissue with a
nonabsorbable suture. External registration of HR
using surface needle electrodes was used to control
the placement of the implanted electrodes to ensure
that the HR transmitters were functioning correctly.
After final placement of each transmitter, the skin
incision was closed by an interrupted horizontal
mattress pattern with nonabsorbable, multifilament
sutures (Mersilencet 2-0 USP, Ethicon). No post-
operative analgesics were administered. The foxes
were kept indoors in small cages for 1–2 days for
recovery, with regular observations before being
returned to their outdoor holding cages.
RESULTS
One fox, a female, anesthetized with xylazine–
ketamine died 80 min after the beginning of the first
surgery in 1995, whereas two male foxes anesthe-
tized with medetomidine–ketamine died 30–35 min
after the beginning of surgery in 1996 (during the
second procedure performed on each of these in-
dividuals). Necropsies were not performed.
After administration of medetomidine–ketamine,
FSS occurred within 1.5 6 0.4 min, LR after 2.6
6 0.7 min, and CI after 6.8 6 1.3 min. These pa-
rameters were not recorded in animals anesthetized
with xylazine–ketamine. In one medetomidine–ke-
tamine immobilization, the initial dose was not suf-
ficient to induce anesthesia nor were six supple-
mental doses of medetomidine–ketamine given
over the next 1.5 hr. The total supplemental dose
given to this fox was 0.06 mg/kg medetomidine and
3.6 mg/kg ketamine, or 1.2 times the initial dose.
Further procedures were not performed, and the an-
imal was released into its outdoor holding cage.
Another animal became restless after the initial
dose, running and jumping intensively in its cage,
but reached CI first after 18 min. It was given a
supplemental dose of the anesthetic 3 min after
reaching CI. Two of the four foxes that were given
xylazine–ketamine vomited shortly after drug ad-
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Figure 1. Illustration of how the electrode wire’s dis-
tal end was prepared to form a nonopening loop before
implantation A. Illustration of the two different electrode
placements under the skin. B. Illustration of how the three
parallel mersilene thread belts were formed around each
transmitter, showing the position of the small mersilene
loops on opposite sides of the transmitter, which were
used as anchoring points to facilitate attachment to the
abdominal wall C.
Table 2. Ranges and means 6 SD for respiratory rate
(RR; respirations per minute [rpm]), heart rate (HR; beats
per minute [bpm]), HR within 5 min after supplemental
doses of anesthesia were administered (HR supl), and rec-
tal temperature (Tr) in 8C of arctic foxes during anesthesia
and surgery, but before the first incision was made.
Num-
ber
of
ani-
mals
Num-
ber of
record-
ings Range Mean 6 SD
RR (rpm)a
HR (bpm)a
HR supl (bpm)a
Tr (8C)a
RR (rpm)b
HR (bpm)b
HR supl (bpm)b
Tr (8C)b
4
4
3
4
8
8
8
8
4
4
3
4
17
18
18
18
30–36
105–127
117–130
37.5–39.5
24–45
93–147
97–149
37.7–40.6
33 6 3
120 6 10
123 6 7
38.7 6 1.0
32 6 6
119 6 17
121 6 16
39.0 6 0.9
a Xylazine plus ketamine: 1.2 plus 25 mg/kg, respectively.
b Medetomidine plus ketamine: 0.05 plus 3 mg/kg, respectively.
ministration. One of these also had tonic convul-
sions during the surgery. One of the four animals
that was given xylazine–ketamine spontaneously
recovered during surgery, but supplemental anes-
thetic quickly reversed this situation. In foxes anes-
thetized with medetomidine–ketamine, vomiting
occurred in 13 of 20 cases (65%) shortly after drug
administration. No tonic convulsions or spontane-
ous recoveries were observed in any of these ani-
mals.
Mean values of RR, HR, HR within 5 min after
supplemental anesthesia, and Tr before the first skin
incision in foxes anesthetized with xylazine–keta-
mine and medetomidine–ketamine are given in Ta-
ble 2. With both xylazine–ketamine and medetom-
idine–ketamine, HR normally increased briefly
within the first 5 min after each supplemental dose
of anesthesia (Table 2), being more evident in some
foxes compared with others. The mean time from
initial administration of the anesthetic combinations
to incision of the skin was 38 6 7 min (range 25–
52). From the first incision until the skin was su-
tured, Tr dropped by 1.1 6 0.08C in foxes anesthe-
tized with xylazine–ketamine and by 1.2 6 0.78C
in foxes anesthetized with medetomidine–ketamine.
The time taken from closure of the peritoneum until
skin closure was, on average, about 29 min. During
the interval between closure of the peritoneum and
completion of skin closure (29 6 15 min), Tr in-
creased by 0.2 6 0.38C and 0.7 6 0.68C in foxes
anesthetized with xylazine–ketamine and medetom-
idine–ketamine, respectively.
The first surgical implantation, defined as time
from initial dose of anesthesia to placement of the
last suture, lasted for 73 6 7 min (n 5 6) for Tb
transmitters and for 95 6 13 min (n 5 5) for HR
transmitters. Implantation of transmitters the sec-
ond time involved removal of old transmitters for
battery change and implantation of new ones and
lasted for 92 min for one Tb transmitter and 110 6
10 min (n 5 5) for HR transmitters. The third sur-
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gical intervention involved the same procedure as
the second and lasted for 112 6 19 min (n 5 4)
for HR transmitters, which were the only new trans-
mitters implanted. We experienced no problems
with the retraction of the HR electrodes, anchored
or not, and the HR signals seemed not to be af-
fected by the location of the electrodes or type of
anchoring used.
Apart from the three deaths, all recoveries were
uneventful. All foxes were carefully observed for
several days after surgery, and daily food intake
was recorded. Their activity levels and behaviors
were normal. Eight foxes started to eat within 24
hr of surgery and three foxes within 48 hr. All foxes
were eating a normal amount of food within 3.3 6
1.7 days (n 5 11) after surgery. Wound sites were
not inspected on a daily basis to avoid disturbing
the implanted equipment before it was well an-
chored, and the wounds were healed. At least 6 wk
elapsed after surgery before the foxes participated
in physiologic experiments for energetic studies.3–6
DISCUSSION
Xylazine–ketamine anesthesia caused tonic con-
vulsions, vomiting, and spontaneous recovery. Al-
though there was no published data available in
1996–1997 concerning the use of medetomidine in
wild arctic foxes, medetomidine is a good alterna-
tive to xylazine in carnivore anestheisa,12,13,16 and it
has been used successfully in farmed blue foxes.
We modified the protocols and used published blue
fox medetomidine dosages.11
Medetomidine potentiates the anesthetic effect of
ketamine to a greater extent than does xylazine, re-
ducing the effective ketamine dose by as much as
75%.13 Mortality has not been reported in previous
studies involving medetomidine–ketamine in arctic
foxes and farmed blue foxes.1,11 Necropsies might
have helped determine the cause or causes of our
three fox deaths.
Medetomidine–ketamine induced effective and
reliable anesthesia in the rest of the arctic foxes,
except on one occasion when one fox did not
achieve a surgical plane of anesthesia even after
several supplemental doses. This may have been
due to increased handling time of the fox before
the drugs were administered. Animals should be
kept calm after injection with medetomidine.14 Re-
dosing, as described in this fox, is not recommend-
ed.
One fox with a longer CI time under medetom-
idine–ketamine anesthesia may have received an
s.c. injection of the agents. The dosages of mede-
tomidine (0.05 mg/kg) and ketamine (3.0 mg/kg)
used in the present study are comparable with those
used successfully in farmed blue foxes11 and free-
living wild arctic fox cubs.1 Vomiting during med-
etomidine–ketamine induction has not been report-
ed in farmed blue fox or in arctic fox cubs,1,11 al-
though it has been seen during recovery in 56% of
gray wolves immobilized with the same anesthetic
combination.9
Mean time to CI after immobilization with med-
etomidine–ketamine was 6.8 min. This is long
when compared with the mean time to CI of farmed
blue fox, which was within 2.5 min11 and of arctic
fox cubs, which was within 58–150 sec.1 However,
in approximately 90% of carnivores, the mean time
to CI was within 10 min after darting or hand in-
jections with medetomidine–ketamine combina-
tions.9,13,23
Potential side effects of medetomidine include
bradycardia, decreased cardiac output, hypotension,
emesis, hypersalivation, loss of thermoregulatory
ability, and decreased respiration rate.2,15,22 When
medetomidine is combined with the dissociative an-
esthetic ketamine, immobilization is more com-
plete, and the potential for side effects is re-
duced.13,19 The RR of adult conscious arctic foxes
is about 12 rpm.3 Our mean RR values of 33 and
32 rpm during immobilization with xylazine–keta-
mine and medetomidine–ketamine, respectively,
agree with values reported under similar anesthetic
conditions in red wolves (23–28 rpm and 20–27
rpm, respectively),23 in farmed blue fox (25–35
rpm), in and arctic fox cubs (55 rpm).1,11 Similar
RR increases have been reported in dogs and river
otters.21,24
The mean HR values in arctic foxes anesthetized
with both xylazine–ketamine and medetomidine–
ketamine, 120 bpm and 119 bpm, respectively, are
higher than the mean value of 82 bpm measured in
conscious arctic foxes.3 Heart rates were 156–225
bpm in arctic fox cubs anesthetized with medetom-
idine–ketamine,1 60–120 bpm in farmed blue fox,11
81–104 bpm in red wolves immobilized with xy-
lazine–ketamine, and 82–99 bpm in red wolves im-
mobilized with medetomidine–ketamine.23 A small
transient increase in HR was also recorded in our
animals immediately after the supplemental injec-
tion of medetomidine–ketamine. This is not in
agreement with previous data in dogs and farmed
blue fox, where HR decreased after administration
of the same dosages.11,14 Xylazine–ketamine is also
known to cause cardiovascular depression in the
arctic fox.18 However, HR can increase in dogs, red
wolfs, and arctic fox cubs receiving a2-adrenocep-
tor agonists.1,22,23,25 Because ketamine has cardio-
stimulatory properties, the increase in HR might be
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due to ketamine’s stimulation of the sympathetic
nervous system.20
Mean Tb in adult conscious arctic foxes is 38.58C
during winter and 38.98C in summer.3 The relative-
ly high Tr recorded in some of our immobilized
foxes before surgery (38.7 and 39.08C; Table 2)
may be due to excitement associated with manual
restraint before injection. In these winter-adapted
arctic foxes (i.e., those with winter fur), Tr de-
creased during xylazine-ketamine– and medetomi-
dine-ketamine–induced immobilization. Similarly,
Tb decreased in red wolf immobilized with xylazi-
ne–ketamine and medetomidine–ketamine (from
39.9 to 38.88C and from 39.7 to 38.78C in 50 min,
respectively), farmed blue fox immobilized with
medetomidine–ketamine (from 39.5 to 38.58C in 60
min), and arctic fox cubs immobilized with mede-
tomidine–ketamine (from 39.8 to 39.28C in 18
min).1,11,23 Such a decrease is considered as a char-
acteristic effect of the anesthetic used.15
Postoperative analgesics, although not adminis-
tered in this study, should be considered following
any similar future surgical procedures.
Transmitter implantation in mersilene-netting
should be avoided in relatively small animals where
transmitters need to be removed for battery changes
because complications may result from extensive
ingrowth and vascularization of connective tissue
within the netting. This tissue ingrowth was origi-
nally intended to take over from the anchoring su-
tures and permanently bind the transmitter to the
inside wall of the abdominal cavity. However, in
some foxes, excessive ingrowth extended to the liv-
er, spleen, and stomach. Although the effect of this
was unclear, all the animals showed normal behav-
ior in the weeks and months after the surgical pro-
cedures, participated in further studies,3–6 and sur-
vived for at least 2 yr after the conclusion of the
studies. Connective tissue was much reduced in the
foxes implanted without mersilene-netting. Adhe-
sions can cause problems after implantation without
mersilene-netting, however. Adhesions were seen in
3 of 10 beavers (Castor canadensis) with intraper-
itoneal transmitters, and one of these died due to
intestinal obstruction.7 Retraction of the HR trans-
mitter leads occurred in silver foxes when the leads
were not anchored.17 However, we experienced no
problems with the HR signals or with retraction of
the leads. Electrode placement was not affected by
handling.4
The DataCol 5.0 system has the ability to record
Tb and HR over long distances (at least 100 m).
Test animals can be placed in large enclosures
where they are under less stress. The system gives
reliable physiologic data from captive animals. The
limited duration of battery life is a problem, how-
ever. Studies of annual variation in physiologic pa-
rameters may require that transmitters need to be
reimplanted in small animals, however. Addition-
ally, Tb and HR data must be recorded by separate
transmitters, so two transmitters must be implanted
to simultaneously record both parameters. This was
prohibited by the size of the arctic fox.
In conclusion, we have demonstrated a method
for implanting radio transmitters into the abdominal
cavity of arctic foxes for extended periods of time.
Although mersilene-netting provided good trans-
mitter anchorage, this material caused excessive
amounts of ingrowth of connective tissue, and its
use should be avoided. A simpler and shorter at-
tachment procedure is described to overcome this
problem. The number of deaths (1 of 4 animals
anesthetized with xylazine–ketamine and 2 of 20
surgical procedures with medetomidine–ketamine)
cannot be regarded as acceptable. Although it is
uncertain as to whether or not these were related to
the anesthesia or the surgical procedures (or to
both), it is, nevertheless, recommended that alter-
native anesthetic protocols should be considered for
prolonged surgical procedures in this species.
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